Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040371630> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W3040371630 abstract "Primary central nervous system lymphoma (PCNSL) is a rare malignancy with few treatment options. One regimen used for induction is rituximab, high-dose methotrexate (HD-MTX), procarbazine, and vincristine (R-MPV). A common institutional practice is removing vincristine (VCR) from this regimen due to its poor CNS penetration and associated toxicities. The aim of this study was to evaluate how the omission of VCR from HD-MTX-based induction impacted clinical outcomes.In a retrospective review, patients with PCNSL who received HD-MTX-based induction therapy between January 1, 2010 and May 31, 2018 were evaluated. Patients were stratified according to treatment into 2 groups, VCR-containing therapy versus no VCR. The primary endpoint was complete response (CR) rate following the completion of induction chemotherapy. Secondary endpoints included progression-free survival (PFS), overall survival (OS), and adverse event rate.Twenty-nine patients were included: 16 patients in the VCR group and 13 in the non-VCR group. A CR was achieved in 7 (44%) and 5 (38%) (odds ratio [OR] = 1.24; 95% confidence interval [CI]: 0.28-5.53) patients, respectively. Median OS was 85.3 (95% CI: 20.2-85.3) versus 67.1 months (95% CI: 10.5-NR) and median PFS was 60.7 (95% CI: 9.4-NR) versus 23.7 months (95% CI: 4.7-NR) in the VCR group versus non-VCR group, respectively. The incidence of any grade peripheral neuropathy was higher in the VCR group.CR rate, OS, and PFS were similar between groups regardless of VCR inclusion. Adverse events were higher in the VCR group. Larger studies are required to further evaluate the efficacy of VCR in PCNSL induction regimens." @default.
- W3040371630 created "2020-07-10" @default.
- W3040371630 creator A5007468276 @default.
- W3040371630 creator A5020238544 @default.
- W3040371630 creator A5028280408 @default.
- W3040371630 creator A5037535298 @default.
- W3040371630 creator A5047308475 @default.
- W3040371630 creator A5052688078 @default.
- W3040371630 creator A5061648842 @default.
- W3040371630 date "2020-01-01" @default.
- W3040371630 modified "2023-10-03" @default.
- W3040371630 title "High-dose methotrexate-based regimens with or without vincristine for the treatment of primary central nervous system lymphoma" @default.
- W3040371630 cites W1993570723 @default.
- W3040371630 cites W2024292542 @default.
- W3040371630 cites W2045190885 @default.
- W3040371630 cites W2083597347 @default.
- W3040371630 cites W2102370623 @default.
- W3040371630 cites W2115159072 @default.
- W3040371630 cites W2133390829 @default.
- W3040371630 cites W2168209011 @default.
- W3040371630 cites W2169143399 @default.
- W3040371630 cites W2556517183 @default.
- W3040371630 cites W2620036274 @default.
- W3040371630 cites W2884727463 @default.
- W3040371630 doi "https://doi.org/10.1093/noajnl/vdaa077" @default.
- W3040371630 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7372924" @default.
- W3040371630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32715297" @default.
- W3040371630 hasPublicationYear "2020" @default.
- W3040371630 type Work @default.
- W3040371630 sameAs 3040371630 @default.
- W3040371630 citedByCount "2" @default.
- W3040371630 countsByYear W30403716302021 @default.
- W3040371630 countsByYear W30403716302023 @default.
- W3040371630 crossrefType "journal-article" @default.
- W3040371630 hasAuthorship W3040371630A5007468276 @default.
- W3040371630 hasAuthorship W3040371630A5020238544 @default.
- W3040371630 hasAuthorship W3040371630A5028280408 @default.
- W3040371630 hasAuthorship W3040371630A5037535298 @default.
- W3040371630 hasAuthorship W3040371630A5047308475 @default.
- W3040371630 hasAuthorship W3040371630A5052688078 @default.
- W3040371630 hasAuthorship W3040371630A5061648842 @default.
- W3040371630 hasBestOaLocation W30403716301 @default.
- W3040371630 hasConcept C126322002 @default.
- W3040371630 hasConcept C141071460 @default.
- W3040371630 hasConcept C156957248 @default.
- W3040371630 hasConcept C168563851 @default.
- W3040371630 hasConcept C197934379 @default.
- W3040371630 hasConcept C203092338 @default.
- W3040371630 hasConcept C2776694085 @default.
- W3040371630 hasConcept C2776755627 @default.
- W3040371630 hasConcept C2779338263 @default.
- W3040371630 hasConcept C2779429289 @default.
- W3040371630 hasConcept C2780653079 @default.
- W3040371630 hasConcept C2781059491 @default.
- W3040371630 hasConcept C2781173314 @default.
- W3040371630 hasConcept C2781413609 @default.
- W3040371630 hasConcept C71924100 @default.
- W3040371630 hasConcept C90924648 @default.
- W3040371630 hasConceptScore W3040371630C126322002 @default.
- W3040371630 hasConceptScore W3040371630C141071460 @default.
- W3040371630 hasConceptScore W3040371630C156957248 @default.
- W3040371630 hasConceptScore W3040371630C168563851 @default.
- W3040371630 hasConceptScore W3040371630C197934379 @default.
- W3040371630 hasConceptScore W3040371630C203092338 @default.
- W3040371630 hasConceptScore W3040371630C2776694085 @default.
- W3040371630 hasConceptScore W3040371630C2776755627 @default.
- W3040371630 hasConceptScore W3040371630C2779338263 @default.
- W3040371630 hasConceptScore W3040371630C2779429289 @default.
- W3040371630 hasConceptScore W3040371630C2780653079 @default.
- W3040371630 hasConceptScore W3040371630C2781059491 @default.
- W3040371630 hasConceptScore W3040371630C2781173314 @default.
- W3040371630 hasConceptScore W3040371630C2781413609 @default.
- W3040371630 hasConceptScore W3040371630C71924100 @default.
- W3040371630 hasConceptScore W3040371630C90924648 @default.
- W3040371630 hasIssue "1" @default.
- W3040371630 hasLocation W30403716301 @default.
- W3040371630 hasLocation W30403716302 @default.
- W3040371630 hasLocation W30403716303 @default.
- W3040371630 hasLocation W30403716304 @default.
- W3040371630 hasOpenAccess W3040371630 @default.
- W3040371630 hasPrimaryLocation W30403716301 @default.
- W3040371630 hasRelatedWork W2329773241 @default.
- W3040371630 hasRelatedWork W2360706536 @default.
- W3040371630 hasRelatedWork W2385309123 @default.
- W3040371630 hasRelatedWork W2405404309 @default.
- W3040371630 hasRelatedWork W3024712659 @default.
- W3040371630 hasRelatedWork W3032199847 @default.
- W3040371630 hasRelatedWork W3107525433 @default.
- W3040371630 hasRelatedWork W3188224560 @default.
- W3040371630 hasRelatedWork W4206611950 @default.
- W3040371630 hasRelatedWork W4225853628 @default.
- W3040371630 hasVolume "2" @default.
- W3040371630 isParatext "false" @default.
- W3040371630 isRetracted "false" @default.
- W3040371630 magId "3040371630" @default.
- W3040371630 workType "article" @default.